Cargando…
Zoledronic Acid Sensitizes Renal Cell Carcinoma Cells to Radiation by Downregulating STAT1
Zoledronic acid (ZOL), a third-generation bisphosphonate that strongly inhibits osteoclast activity, is widely used for the treatment of bone metastasis from a variety of malignancies, including renal cell carcinoma (RCC). We previously reported that zoledronic acid (ZOL) clinically potentiates anti...
Autores principales: | Kijima, Toshiki, Koga, Fumitaka, Fujii, Yasuhisa, Yoshida, Soichiro, Tatokoro, Manabu, Kihara, Kazunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669422/ https://www.ncbi.nlm.nih.gov/pubmed/23741352 http://dx.doi.org/10.1371/journal.pone.0064615 |
Ejemplares similares
-
Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year study
por: Tatokoro, Manabu, et al.
Publicado: (2013) -
Heat shock protein 90 targeting therapy: state of the art and future perspective
por: Tatokoro, Manabu, et al.
Publicado: (2015) -
ErbB2 and NFκB Overexpression as Predictors of Chemoradiation Resistance and Putative Targets to Overcome Resistance in Muscle-Invasive Bladder Cancer
por: Koga, Fumitaka, et al.
Publicado: (2011) -
Patient's Self-monitoring of Transurethral Surgical Images Using a Head-mounted Display
por: Ito, Masaya, et al.
Publicado: (2015) -
Instructive head-mounted display system: pointing device using a vision-based finger tracking technique applied to surgical education
por: Yoshida, Soichiro, et al.
Publicado: (2014)